Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.68 |
| ▸ | MAPT | P10636 | 1/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.68 |
| ▸ | HDAC8 | Q9BY41 | 7/20 | 0.65 |
| ▸ | HDAC3 | O15379 | 5/20 | 0.65 |
| ▸ | HDAC6 | Q9UBN7 | 5/20 | 0.65 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.65 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.65 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.61 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.61 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.61 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.61 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.61 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.61 |
| ▸ | CA1 | P00915 | 3/20 | 0.55 |
| ▸ | CA2 | P00918 | 3/20 | 0.55 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7099035 | 0.92 | MEN1 (0.78) | MEN1KMT2AALDH1A1MAPTMAPK1 | |
| SCHEMBL20621920 | 0.92 | MEN1 (0.65) | MEN1KMT2AALDH1A1MAPTMAPK1 | |
| SCHEMBL11518363 | 0.91 | MEN1 (0.81) | MEN1KMT2AALDH1A1MAPTMAPK1 | |
| SCHEMBL29269298 | 0.89 | MEN1 (0.79) | MEN1KMT2AALDH1A1MAPTMAPK1 | |
| SCHEMBL29269467 | 0.89 | MEN1 (0.79) | MEN1KMT2AALDH1A1MAPTMAPK1 | |
| SCHEMBL16289643 | 0.89 | MEN1 (0.79) | MEN1KMT2AALDH1A1MAPTMAPK1 | |
| SCHEMBL3923314 | 0.86 | MEN1 (0.89) | MEN1KMT2AALDH1A1MAPTMAPK1 | |
| SCHEMBL16106143 | 0.85 | MEN1 (0.73) | MEN1KMT2AALDH1A1MAPTMAPK1 | |
| SCHEMBL11652739 | 0.84 | MEN1 (0.86) | MEN1KMT2AALDH1A1MAPTMAPK1 | |
| SCHEMBL28917678 | 0.84 | ALDH1A1 (0.60) | MEN1KMT2AALDH1A1MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090131657-A1 | PROCESS FOR ALKENYLATING CARBOXAMIDES | BASF SE (DE) | 2009-05-21 | — | — | US | disclosed |
| EP-2032527-A1 | PROCESS FOR ALKENYLATING CARBOXAMIDES | BASF SE (DE) | 2009-03-11 | — | — | EP | disclosed |
| WO-2007144281-A1 | PROCESS FOR ALKENYLATING CARBOXAMIDES | BASF SE (DE) | 2007-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131657-A1 | PROCESS FOR ALKENYLATING CARBOXAMIDES | PRMT5, CYC1, CBR3 | MEN1 303/4885KMT2A 41/4885ALDH1A1 1506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.